BGLC financials

BioNexus Gene Lab (BGLC) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

BGLC income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$7.42M$1.09M-$2.97M-$2.98M-1.61
2024$9.51M$1.29M-$1.57M-$1.60M-0.90
2023$9.77M$1.33M-$2.59M-$2.63M-0.17
2022$10.93M$1.26M-$291.18K-$355.97K–
2021$13.36M$2.27M$1.06M$751.57K–
2020$11.39M$1.72M$1.27M$1.09M0.01